In a sign that exposure to certain endocrine-disrupting chemicals may be playing a role in cancers of the breast, ovary, skin and uterus, researchers have found that people who developed those cancers have significantly higher levels of these chemicals in their bodies.
While it does not prove that exposure to chemicals like PFAS and phenols led to these cancer diagnoses, it is a strong signal that they may be playing a role and should be studied further.
The study showed that particularly for women, higher exposure to PFDE, a long-chained PFAS compound, had double the odds of a previous melanoma diagnosis; women with higher exposure to two other long-chained PFAS compounds, PFNA and PFUA, had nearly double the odds of a prior melanoma diagnosis.